Alan P. C. Gou

Alan P. C. Gou

Auto-generated profile, based on publicly available information

Alan P. C. Gou

Faculty of Medicine, Memorial University of Newfoundland, Faculty of Medicine, St. John's, Newfoundland and Labrador, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2024 in Plastic Surgery
Verified
Journal Article
Open access
AGAlan Gou
Alan Gou
MBMichelle Bonapace-Potvin
Michelle Bonapace-Potvin
Blair Robert PetersBlair Robert Peters
Blair Robert Peters
Purpose: While visibility and acceptance of the transgender community have increased across Canada, barriers persist in accessing gender-affirming surgeries (GAS). This study aims to determine the current state of GAS care in Canada, focusing on insurance coverage by province and identifying regions needing the development of specialized GAS programs. Methods: This cross-sectional study was conducted by examining provincial health ministry webpages and contacting health authorities and gender clinics to collect data on GAS coverage. Information on various procedures, including chest surgery, facial GAS, and genital surgeries was collected to determine which procedures are covered in each respective province. Geographic distribution of clinics that perform GAS procedures in Canada was also collected and sorted by referrals in-province and out-of-province. Results: There are 32 unique gender-affirming procedures covered by Canadian provincial health plans. Prince Edward Island provides the highest coverage of GAS procedures, while Nunavut covers the least. Quebec offers the most comprehensive in-province GAS program, with some in-province care available in the other provinces. The three territories generally lack access to any in-province procedures. Conclusions: Coverage for gender-affirming surgical procedures in Canada varies widely. Genital procedures have the most comprehensive coverage, chest surgeries are covered by most provinces, and facial GAS were only covered in two provinces. There is also a disparity between coverage and availability of GAS in most provinces. Physicians should advocate for broader coverage and targeted training and recruitment of GAS specialized surgeons in key geographic regions.

1 January 2024 in Multiple Sclerosis International
Verified
Journal Article
Open access
PDF file
SBSyamala Buragadda
Syamala Buragadda
NSNicholas Snow
Nicholas Snow
AGAlan P. C. Gou
Alan P. C. Gou
JMJoshua McShane
Joshua McShane
CNCaitlin J. Newell
Caitlin J. Newell
Michelle PloughmanMichelle Ploughman
Michelle Ploughman
Purpose. The link between moderate‐ to vigorous‐intensity physical activity (MVPA) and cardiorespiratory fitness in individuals with multiple sclerosis (MS) remains unclear. This study examined the relationship between self‐reported MVPA and objectively assessed cardiorespiratory fitness, emphasizing sex differences. Methods. 107 adults with MS (77 females), aged (mean ± standard deviation) 47.2 ± 10.2 years, were recruited from a local MS clinic. Fitness was measured as maximal oxygen uptake (V̇O2max) during a graded maximal exercise test using a recumbent stepper. MVPA (24‐hour recall) was estimated as the duration of activities ≥ 3 MET (metabolic equivalent of task). MET‐minutes were calculated by multiplying MET by duration. We explored sex differences in self‐reported MVPA, cardiorespiratory fitness, and disability; examined sex differences in associations between these variables; and investigated whether MET‐minutes of MVPA predicted V̇O2max in females and males. Results. Mean V̇O2max was 24.79 mL·kg-1·min-1, indicating poor cardiorespiratory fitness levels, despite high levels of self‐reported MVPA (mean = 412.5 MET‐minutes). Fifty‐three percent of males and 40% of females had V̇O2max levels below the 20th age‐ and sex‐standardized population percentile, indicating poor cardiorespiratory fitness. There were statistically significant associations between MVPA and V̇O2max (Rho = 0.27, p = .01), as well as disability and V̇O2max (Rho = −0.35, p = .02), in females but not males. A regression model using sex, age, body mass, disability, and MVPA to estimate V̇O2max was valid in predicting V̇O2max values that were statistically equivalent to those measured in the laboratory in females but not males. However, the inclusion of MVPA did not add to the predictive value of this equation. Conclusions. Despite reporting high levels of MVPA, people with MS had poor cardiorespiratory fitness. MVPA, fitness, and disability were associated in females only, indicating that sex differences should be considered in fitness appraisal. Self‐reported MVPA did not predict fitness, suggesting 24‐hour recall may not be representative of true activity or fitness levels in persons with MS. Future work should examine sex differences in associations between MVPA and fitness using objective measures such as accelerometry.